Back to BlackRock, Inc. BlackRock, Inc.

ARWRARWR
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ARROWHEAD PHARMACEUTICALS IN

BlackRock, Inc. holds 14.8M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $1.2B as of 2026-Q2. The position was decreased (-18.3% shares). ARWR represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$1.2B

Current Shares

14.8M

Total Value Change

+$904.7M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
14.8M
-18.3%
$1.2B0.0%$81.51
0
2026-Q1
Decreased
18.2M
-14.8%
$1.1B0.0%$64.10
0
2025-Q4
Increased
21.3M
+5.4%
$1.4B0.0%$67.25
34
2025-Q3
Increased
20.2M
+4.1%
$697.6M0.0%$33.78
33
2025-Q2
Decreased
19.4M
-2.5%
$306.9M0.0%$16.08
0
2025-Q1
Increased
19.9M
+23.2%
$253.9M0.0%$13.82
37
2024-Q4
New
16.2M
-
$304.1M0.0%$18.61
43

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used